Manfred Kindler

A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients

Michael Siebels, K. Rohrmann, R. Oberneder et al. · World Journal of Urology · 2010 · 101 citations

Urology, Genitourinary Cancer, Medicine +6

A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancer

Helmut Oettle, M. Arning, Uwe Pelzer et al. · Annals of Oncology · 2000 · 53 citations · Full text

Oncology, Phase Ii Trial, Pancreatic Cancer +6

Prospective, Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase III Study with Orally Administered Budesonide for Prevention of Irinotecan (CPT-11)-Induced Diarrhea in Patients with Advanced Colorectal Cancer

Meinolf Karthaus, Harald Balló, W. Abenhardt et al. · Oncology · 2005 · 48 citations

Effectiveness of Nicorandil (SG-75), a New Long-Acting Drug with Nitroglycerin Effects, in Patients with Coronary Artery Disease

J Thormann, M. Schlepper, W Krämer et al. · Journal of Cardiovascular Pharmacology · 1983 · 41 citations

Heart Failure, Cardiovascular Pharmacology, Pharmacotherapy +22

Effects of AR-L 115 BS (Sulmazol), a new cardiotonic agent, in coronary artery disease: Improved ventricular wall motion, increased pump function and abolition of pacing-induced ischemia

J Thormann, M. Schlepper, Wilfried Kramer et al. · Journal of the American College of Cardiology · 1983 · 29 citations

Cardiovascular Disease, Pharmacology, Cardiovascular Pharmacology +7